Mashudu Nemukula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mashudu Nemukula has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Arun Kumar Malaisamy
3 shared publicationsNeel Sarovar Bhavesh
3 shared publicationsSechene Stanley Gololo
3 shared publications- Sechene Stanley Gololo
Sefako Makgatho Health Sciences University
3 shared publications Fentahun Adane
2 shared publicationsHarold Majane
2 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Serum metabolomic dysregulation reveals systemic pathophysiology of type 2 diabetes mellitus in black South African ancestry
- 8 August 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Open AccessSerum metabolomic dysregulation reveals systemic pathophysiology of type 2 diabetes mellitus in black South African ancestry
- Open Access
- 19 June 2026
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 10 (4) , 025380402
Diabetic dyslipidaemia and its predictors among hyperglycaemic patients in South Africa: A systematic review and meta-analysis
Introduction: Diabetic dyslipidaemia is a growing public health concern, especially among patients with diabetes. Despite advancements in diabetes management, diabetic dyslipidaemia remains prevalent and contributes to increased morbidity and mortality rates. Understanding its impact, particularly in South Africa, is crucial for developing effective interventions. Objective: The review aims to address these gaps by systematically analysing existing published studies on diabetic dyslipidaemia, estimating its pooled prevalence, and identifying factors associated with its occurrence. Methods: The systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist guidelines. Eligible studies were sought in electronic databases using search keywords. The Joanna Briggs Institute critical appraisal checklist tool was used to assess the quality of studies. STATA 17 software was used for meta-analysis to compute the pooled prevalence with a 95% confidence interval. Results: Ten eligible studies were included. The pooled prevalence of diabetic dyslipidaemia among the South African hyperglycaemic population was 71.56% (95% CI: 56.61–86.52). Sub-group analysis by region reported that the highest prevalence of diabetic dyslipidaemia was 89% (95% CI: 82.87–95.13) in the Western Cape province. The urban population was projected to have the highest prevalence of 79.97% (95% CI: 64.80–95.14). The most frequently reported pattern of diabetic dyslipidaemia was elevated LDL-C, accounting for 59% (95% CI: 43.58–75.93) of the studies. Body mass index (BMI) was the most reported predictor across multiple studies. Conclusion: These findings of the current study suggest that there is an urgent need to strengthen lipid management strategies in the South African diabetic population.
- 19 June 2026
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 10 (4) , 025380402
Open AccessDiabetic dyslipidaemia and its predictors among hyperglycaemic patients in South Africa: A systematic review and meta-analysis
Introduction: Diabetic dyslipidaemia is a growing public health concern, especially among patients with diabetes. Despite advancements in diabetes management, diabetic dyslipidaemia remains prevalent and contributes to increased morbidity and mortality rates. Understanding its impact, particularly in South Africa, is crucial for developing effective interventions. Objective: The review aims to address these gaps by systematically analysing existing published studies on diabetic dyslipidaemia, estimating its pooled prevalence, and identifying factors associated with its occurrence. Methods: The systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist guidelines. Eligible studies were sought in electronic databases using search keywords. The Joanna Briggs Institute critical appraisal checklist tool was used to assess the quality of studies. STATA 17 software was used for meta-analysis to compute the pooled prevalence with a 95% confidence interval. Results: Ten eligible studies were included. The pooled prevalence of diabetic dyslipidaemia among the South African hyperglycaemic population was 71.56% (95% CI: 56.61–86.52). Sub-group analysis by region reported that the highest prevalence of diabetic dyslipidaemia was 89% (95% CI: 82.87–95.13) in the Western Cape province. The urban population was projected to have the highest prevalence of 79.97% (95% CI: 64.80–95.14). The most frequently reported pattern of diabetic dyslipidaemia was elevated LDL-C, accounting for 59% (95% CI: 43.58–75.93) of the studies. Body mass index (BMI) was the most reported predictor across multiple studies. Conclusion: These findings of the current study suggest that there is an urgent need to strengthen lipid management strategies in the South African diabetic population.
- Open Access
- 19 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e82716
Diabetic Dyslipidemia and Its Determinants Among People With Diabetes in South Africa: Protocol for a Systematic Review and Meta-Analysis
Background: Diabetic dyslipidemia (DD), characterized by a classical triad of abnormal lipid profiles among the diabetic population, presents a major public health concern in South Africa, particularly among Black South Africans. The increasing prevalence of DD significantly contributes to the development of atherosclerotic cardiovascular disease. With the incidence of diabetes rising from 4.5% in 2010 to 12.7% in 2021, urgent preventive measures and effective treatments are crucial to tackle the risk of premature mortality. Objective: This systematic review and meta-analysis protocol aims to examine the existing literature on DD, providing an understanding of its prevalence and associated predictors among the diabetic population in South Africa, with the intention of informing more effective clinical and public health interventions. Methods: The protocol is registered in PROSPERO (International Prospective Register of Systematic Reviews) and will adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The available literature on DD will be systematically searched in common scholarly databases and reviewed accordingly. All published and unpublished studies conducted in South Africa prior to 2024 and written in English will be included. Two members (MN and FA) of the review team will independently screen the studies identified through the database search and assess risk of bias using the revised JBI critical appraisal tools. The review will integrate both quantitative and qualitative data synthesis. Results from both qualitative and quantitative data synthesis will be presented through forest plots, subgroup forest plots, and summary tables, which will present findings on pooled prevalence, odds ratios for predictors, heterogeneity statistics, and sensitivity analyses. Results: The protocol was finalized in January 2025. The literature search was conducted between October 2024 and March 2025. Title and abstract screening began in April 2025, and full-text review was completed by July 2025, with data extraction scheduled for completion by September 2025. The completion of statistical analyses is expected by October 2025. We anticipate submission of the completed systematic review and meta-analysis for publication in December 2025. Conclusions: The findings of the study protocol will inform the design of targeted interventions and policies aimed at advancing the management of DD and subsequently reducing the increased risk of atherosclerotic cardiovascular disease among the diabetic population.
- 19 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e82716
Open AccessDiabetic Dyslipidemia and Its Determinants Among People With Diabetes in South Africa: Protocol for a Systematic Review and Meta-Analysis
Background: Diabetic dyslipidemia (DD), characterized by a classical triad of abnormal lipid profiles among the diabetic population, presents a major public health concern in South Africa, particularly among Black South Africans. The increasing prevalence of DD significantly contributes to the development of atherosclerotic cardiovascular disease. With the incidence of diabetes rising from 4.5% in 2010 to 12.7% in 2021, urgent preventive measures and effective treatments are crucial to tackle the risk of premature mortality. Objective: This systematic review and meta-analysis protocol aims to examine the existing literature on DD, providing an understanding of its prevalence and associated predictors among the diabetic population in South Africa, with the intention of informing more effective clinical and public health interventions. Methods: The protocol is registered in PROSPERO (International Prospective Register of Systematic Reviews) and will adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The available literature on DD will be systematically searched in common scholarly databases and reviewed accordingly. All published and unpublished studies conducted in South Africa prior to 2024 and written in English will be included. Two members (MN and FA) of the review team will independently screen the studies identified through the database search and assess risk of bias using the revised JBI critical appraisal tools. The review will integrate both quantitative and qualitative data synthesis. Results from both qualitative and quantitative data synthesis will be presented through forest plots, subgroup forest plots, and summary tables, which will present findings on pooled prevalence, odds ratios for predictors, heterogeneity statistics, and sensitivity analyses. Results: The protocol was finalized in January 2025. The literature search was conducted between October 2024 and March 2025. Title and abstract screening began in April 2025, and full-text review was completed by July 2025, with data extraction scheduled for completion by September 2025. The completion of statistical analyses is expected by October 2025. We anticipate submission of the completed systematic review and meta-analysis for publication in December 2025. Conclusions: The findings of the study protocol will inform the design of targeted interventions and policies aimed at advancing the management of DD and subsequently reducing the increased risk of atherosclerotic cardiovascular disease among the diabetic population.
- Open Access
- 4 January 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (1) , 8
Distribution of ApoE Gene Polymorphism and Its Association with the Lipid Profile Among Type 2 Diabetes Mellitus Black South Africans
Background: ApoE is a major regulator of lipid metabolism and glycaemic control. The aim of the current study is to investigate the ApoE gene polymorphisms among Black South Africans with and without type 2 diabetes mellitus (T2DM) and associate them with their lipid profile. Methods: A cross-sectional case–control study was conducted among 107 participants, divided into two groups: patients with T2DM (n = 65) and non-diabetic controls (n = 42). Blood samples were collected for analysis of glycated haemoglobin, lipid profile, nitric oxide, high-sensitivity C-reactive protein and DNA genotyping using the MALDI-TOF. Continuous variables were analysed using Student’s t-test or one-way analysis of variance (ANOVA). Genotype and allele frequencies were compared using Fisher’s exact tests. Results: The ApoE3 allele was the most prevalent among both groups, observed in 55.47% in T2DM patients and 52.38% in the non-diabetic group, followed by E4 and E2. HWE analysis revealed a deviation from equilibrium [χ2 (3) = 9.137, p = 0.0275]. TG levels differed significantly across ApoE alleles (F = 3.68, p = 0.03), with higher TG concentrations observed among E3 allele carriers and E4 allele carriers. Poor glycaemic control (HbA1c ≥ 7.0%) predominated across all ApoE alleles. Among E3 allele carriers, 75.0% of participants exhibited poor glycaemic control, whereas only 25.0% achieved good glycaemic control (p = 0.002). Conclusions: ApoE polymorphisms are associated with allele-specific heterogeneity in lipid metabolism and glycaemic control among individuals with T2DM, underscoring the complex, context-dependent role of genetic variation in metabolic dysregulation within African populations.
- 4 January 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (1) , 8
Open AccessDistribution of ApoE Gene Polymorphism and Its Association with the Lipid Profile Among Type 2 Diabetes Mellitus Black South Africans
Background: ApoE is a major regulator of lipid metabolism and glycaemic control. The aim of the current study is to investigate the ApoE gene polymorphisms among Black South Africans with and without type 2 diabetes mellitus (T2DM) and associate them with their lipid profile. Methods: A cross-sectional case–control study was conducted among 107 participants, divided into two groups: patients with T2DM (n = 65) and non-diabetic controls (n = 42). Blood samples were collected for analysis of glycated haemoglobin, lipid profile, nitric oxide, high-sensitivity C-reactive protein and DNA genotyping using the MALDI-TOF. Continuous variables were analysed using Student’s t-test or one-way analysis of variance (ANOVA). Genotype and allele frequencies were compared using Fisher’s exact tests. Results: The ApoE3 allele was the most prevalent among both groups, observed in 55.47% in T2DM patients and 52.38% in the non-diabetic group, followed by E4 and E2. HWE analysis revealed a deviation from equilibrium [χ2 (3) = 9.137, p = 0.0275]. TG levels differed significantly across ApoE alleles (F = 3.68, p = 0.03), with higher TG concentrations observed among E3 allele carriers and E4 allele carriers. Poor glycaemic control (HbA1c ≥ 7.0%) predominated across all ApoE alleles. Among E3 allele carriers, 75.0% of participants exhibited poor glycaemic control, whereas only 25.0% achieved good glycaemic control (p = 0.002). Conclusions: ApoE polymorphisms are associated with allele-specific heterogeneity in lipid metabolism and glycaemic control among individuals with T2DM, underscoring the complex, context-dependent role of genetic variation in metabolic dysregulation within African populations.
- Open Access
The Magnitude of Dyslipidemia and Factors Associated with Elevated LDL-C Among Black South Africans with Type 2 Diabetes Mellitus at a Tertiary Hospital
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health challenge with a significant impact on human life. The current study aims to provide a comprehensive analysis of the magnitude of dyslipidemia and the factors associated with elevated LDL-C levels among Black South Africans with T2DM. Methods: This was a cross-sectional study conducted in a tertiary hospital. Blood samples for glycated hemoglobin (HbA1c) and lipid profile were collected from the study participants and analyzed using Siemens Atellica™ analyzer. The data was entered into Microsoft excel and analyzed using SPSS version 24. Bivariate and multivariate logistic regression was employed to identify variables significantly associated with the outcomes, with a p-value ≤ 0.05 and a 95% confidence interval. Results: A total of 194 study participants with T2DM were recruited in the study. The overall prevalence of dyslipidemia was 90.72%. Of those with dyslipidemia, 40.9% had an isolated dyslipidemia, 39.7% had a combined dyslipidemia and 19.3% had atherogenic dyslipidemia. Significant factors associated with elevated levels of LDL-C included age, non-adherence to treatment (NAT) and duration. However, after multivariate analysis, NAT was found to be an independent associated factor with elevated levels of LDL-C (AOR: 4.596; 95% CI: 0.177–2.874; p = 0.027). Conclusions: Our study found that dyslipidemia is highly prevalent among Black South African patients with T2DM at a tertiary hospital, despite the use of lipid-lowering therapy. NAT was significantly associated with elevated levels of LDL-C. However, it is important to note that the study employed a cross-sectional design, conducted at a single hospital, which may impair the generalizability of the findings.
Open AccessThe Magnitude of Dyslipidemia and Factors Associated with Elevated LDL-C Among Black South Africans with Type 2 Diabetes Mellitus at a Tertiary Hospital
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health challenge with a significant impact on human life. The current study aims to provide a comprehensive analysis of the magnitude of dyslipidemia and the factors associated with elevated LDL-C levels among Black South Africans with T2DM. Methods: This was a cross-sectional study conducted in a tertiary hospital. Blood samples for glycated hemoglobin (HbA1c) and lipid profile were collected from the study participants and analyzed using Siemens Atellica™ analyzer. The data was entered into Microsoft excel and analyzed using SPSS version 24. Bivariate and multivariate logistic regression was employed to identify variables significantly associated with the outcomes, with a p-value ≤ 0.05 and a 95% confidence interval. Results: A total of 194 study participants with T2DM were recruited in the study. The overall prevalence of dyslipidemia was 90.72%. Of those with dyslipidemia, 40.9% had an isolated dyslipidemia, 39.7% had a combined dyslipidemia and 19.3% had atherogenic dyslipidemia. Significant factors associated with elevated levels of LDL-C included age, non-adherence to treatment (NAT) and duration. However, after multivariate analysis, NAT was found to be an independent associated factor with elevated levels of LDL-C (AOR: 4.596; 95% CI: 0.177–2.874; p = 0.027). Conclusions: Our study found that dyslipidemia is highly prevalent among Black South African patients with T2DM at a tertiary hospital, despite the use of lipid-lowering therapy. NAT was significantly associated with elevated levels of LDL-C. However, it is important to note that the study employed a cross-sectional design, conducted at a single hospital, which may impair the generalizability of the findings.
- Open Access
- 20 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Diabetic dyslipidaemia and its determinants among people with diabetes in South Africa: a systematic review and me-ta-analysis protocol (Preprint)
UNSTRUCTURED Diabetic dyslipidaemia (DD), characterized by a classical triad of abnormal lipid profiles among the diabetes population, presents a major public health concern in South Africa, particularly among Black South Africans. The increasing prevalence of DD significantly contributes to the development of atherosclerotic cardiovascular disease (ACVD). With the incidence of diabetes rising from 4.5% in 2010 to 12.7% by 2021, urgent preventive measures and effective treatments are crucial to tackle the risk of premature mortality. This systematic review and meta-analysis protocol seeks to examine the existing literature on DD to provide an understanding of its prevalence and associated predictors among the diabetic population in South Africa, with the intention of informing more effective clinical and public health interventions. The available literature on DD will be systematically searched in the common scholarly database and reviewed accordingly. All published and un-published studies conducted in South Africa before the year 2024, written in English will be in-cluded. The results of the analysis will aid in crafting the design of targeted interventions and pol-icies to advance the management of DD and, subsequently, to reduce the increased risk of ACVD among the diabetic population. This protocol has been registered in the PROSPERO database (ID: CRD42024614221).
- 20 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDiabetic dyslipidaemia and its determinants among people with diabetes in South Africa: a systematic review and me-ta-analysis protocol (Preprint)
UNSTRUCTURED Diabetic dyslipidaemia (DD), characterized by a classical triad of abnormal lipid profiles among the diabetes population, presents a major public health concern in South Africa, particularly among Black South Africans. The increasing prevalence of DD significantly contributes to the development of atherosclerotic cardiovascular disease (ACVD). With the incidence of diabetes rising from 4.5% in 2010 to 12.7% by 2021, urgent preventive measures and effective treatments are crucial to tackle the risk of premature mortality. This systematic review and meta-analysis protocol seeks to examine the existing literature on DD to provide an understanding of its prevalence and associated predictors among the diabetic population in South Africa, with the intention of informing more effective clinical and public health interventions. The available literature on DD will be systematically searched in the common scholarly database and reviewed accordingly. All published and un-published studies conducted in South Africa before the year 2024, written in English will be in-cluded. The results of the analysis will aid in crafting the design of targeted interventions and pol-icies to advance the management of DD and, subsequently, to reduce the increased risk of ACVD among the diabetic population. This protocol has been registered in the PROSPERO database (ID: CRD42024614221).
- Open Access
- 2 August 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (15) , 5581
Association of Carboxyhemoglobin Levels with Peripheral Arterial Disease in Chronic Smokers Managed at Dr George Mukhari Academic Hospital
Chronic cigarette smokers (CCS) are known to have elevated levels of carboxyhemoglobin (COHb). However, it is not known whether increased levels of COHb are associated with endothelial dysfunction (ED), and therefore the development of peripheral arterial disease (PAD). The aim of the study was to investigate the association of blood COHb and plasma nitric oxide (NO) levels, and whether it is an independent risk factor in the development of PAD among CCS at Dr George Mukhari Academic Hospital (DGMAH). A sample of 120 CCS with PAD and a convenience sample of 100 CCS without PAD were recruited into the study. Blood COHb levels were measured using the ABL 90 FLEX CO-oximeter automated spectroscopy. Plasma nitric oxide (NO) levels were measure using ELISA. Logistic regression analysis was used to investigate the association of blood COHb and plasma NO with PAD. Blood COHb levels of CCS with PAD were significantly higher than those of CCS without PAD, and the NO levels of CCS with PAD were significantly lower than those of CCS without PAD. Although both the blood COHb and plasma NO in CCS were significantly associated with PAD in bivariate logistic analysis, only plasma NO was independently associated with PAD in multivariate logistic analysis. This finding is consistent with the hypothesis that COHb is a cause of arterial damage in PAD, leading to reduced NO, and therefore reduced arterial dilation.
- 2 August 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (15) , 5581
Open AccessAssociation of Carboxyhemoglobin Levels with Peripheral Arterial Disease in Chronic Smokers Managed at Dr George Mukhari Academic Hospital
Chronic cigarette smokers (CCS) are known to have elevated levels of carboxyhemoglobin (COHb). However, it is not known whether increased levels of COHb are associated with endothelial dysfunction (ED), and therefore the development of peripheral arterial disease (PAD). The aim of the study was to investigate the association of blood COHb and plasma nitric oxide (NO) levels, and whether it is an independent risk factor in the development of PAD among CCS at Dr George Mukhari Academic Hospital (DGMAH). A sample of 120 CCS with PAD and a convenience sample of 100 CCS without PAD were recruited into the study. Blood COHb levels were measured using the ABL 90 FLEX CO-oximeter automated spectroscopy. Plasma nitric oxide (NO) levels were measure using ELISA. Logistic regression analysis was used to investigate the association of blood COHb and plasma NO with PAD. Blood COHb levels of CCS with PAD were significantly higher than those of CCS without PAD, and the NO levels of CCS with PAD were significantly lower than those of CCS without PAD. Although both the blood COHb and plasma NO in CCS were significantly associated with PAD in bivariate logistic analysis, only plasma NO was independently associated with PAD in multivariate logistic analysis. This finding is consistent with the hypothesis that COHb is a cause of arterial damage in PAD, leading to reduced NO, and therefore reduced arterial dilation.